Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (Tirapazamine) and by nicotinamide with carbogen

This publication has 22 references indexed in Scilit:

• The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography
  British Journal of Cancer, 1992
• Carbogen and nicotinamide: expectations too high? (response to J. Martin Brown)
  Radiotherapy and Oncology, 1992
• Carbogen and nicotinamide: expectations too high?
  Radiotherapy and Oncology, 1992
• SR 4233: A tumor specific radiosensitizer active in fractionated radiation regimes
  Radiotherapy and Oncology, 1991
• Nicotinamide and the hypoxia problem
  Radiotherapy and Oncology, 1991
• Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation
  International Journal of Radiation Oncology*Biology*Physics, 1991
• SR 4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures
  British Journal of Cancer, 1991
• Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo
  British Journal of Cancer, 1991
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1988
• RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER
  The Lancet, 1977